Effect of sorafenib in symptomatic metastatic medullary thyroid cancer

F. Kober,Michael Hermann,A. Handler,G. Krotla

Effect of sorafenib in symptomatic metastatic medullary thyroid cancer

2007

F. Kober
Michael Hermann
A. Handler
G. Krotla

14065 Background: RET receptor tyrosin kinase activity plays a major role in medullary thyroid cancer (MTC) tumor growth. Sorafenib is an oral agent that selectively targets RET tyrosine kinases. M...

Keywords:

Cancer research
Medullary thyroid cancer
Sorafenib
Medicine
Pathology
kinase activity
Receptor
tumor growth
Tyrosine kinase
oral agents

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations